Microbot Medical (MBOT) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free MBOT Stock Alerts $0.97 +0.04 (+4.31%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 1:12 AM | investorplace.comMBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024April 29, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell HealthApril 29, 2024 | globenewswire.comMicrobot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™April 18, 2024 | msn.comMicrobot Medical (MBOT) Price Target Decreased by 12.50% to 7.14April 16, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Halozyme (HALO), Cognition Therapeutics (CGTX)April 15, 2024 | globenewswire.comMicrobot Medical Shares Status Following Recent Geopolitical EventsMarch 28, 2024 | msn.com3 AI Stocks Wall Street Expects to Return Up to 595% in 2024March 27, 2024 | investorplace.comMBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023March 16, 2024 | ca.finance.yahoo.comMBOT Apr 2024 3.000 callFebruary 26, 2024 | benzinga.comMicrobot Medical Stock (NASDAQ:MBOT) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comMBOT Jul 2024 2.500 putFebruary 21, 2024 | finance.yahoo.comMBOT Apr 2024 5.000 callFebruary 18, 2024 | finance.yahoo.comMBOT Mar 2024 2.500 callFebruary 5, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USFebruary 5, 2024 | msn.comMicrobot files FDA application for clinical study of Liberty systemFebruary 5, 2024 | finance.yahoo.comMicrobot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USFebruary 2, 2024 | benzinga.comLooking Into Microbot Medical's Recent Short InterestJanuary 31, 2024 | msn.comMicrobot Medical Settles: Regulation FD Disclosure UpdateJanuary 30, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersJanuary 30, 2024 | msn.comMicrobot Medical announces settlement resolving legal mattersJanuary 30, 2024 | finance.yahoo.comMicrobot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersJanuary 18, 2024 | finance.yahoo.comMicrobot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyDecember 29, 2023 | marketwatch.comMicrobot Medical Shares Drop 20% After Exercising Investment OptionsDecember 29, 2023 | msn.comGold Moves Lower; Microbot Medical Shares SlideDecember 29, 2023 | msn.comMicrobot Medical down 22%, exercises investment options for $2.73M proceedsDecember 29, 2023 | finance.yahoo.comMicrobot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesDecember 28, 2023 | msn.comMicrobot to advance Liberty Robotic System into pivotal clinical trialDecember 28, 2023 | markets.businessinsider.comMicrobot Medical Announces Positive Results For GLP Pivotal Pre-Clinical Study; Stock Up 15%December 28, 2023 | msn.comMicrobot Medical Stock Is Moving Higher: What's Going On?December 28, 2023 | finance.yahoo.comMicrobot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were MetDecember 20, 2023 | fool.comMicrobot Medical (NASDAQ: MBOT)December 14, 2023 | markets.businessinsider.comMicrobot Medical Collaborates With Corewell Health To Enable Telerobotics Between Remote CentersDecember 14, 2023 | finance.yahoo.comMicrobot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for TeleroboticDecember 8, 2023 | morningstar.comMicrobot Medical Inc MBOTDecember 7, 2023 | finance.yahoo.comMicrobot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical StudyNovember 23, 2023 | seekingalpha.comMBOT Microbot Medical Inc.November 21, 2023 | finance.yahoo.comMicrobot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial ActivitiesNovember 17, 2023 | msn.comMicrobot Medical files for $75M mixed securities shelfNovember 13, 2023 | finance.yahoo.comMicrobot Medical Successfully Completed Integral Part of the Verification and Validation ProcessNovember 8, 2023 | finance.yahoo.comMicrobot Medical Granted Registered Trademark from The U.S. Patent and Trademark OfficeOctober 31, 2023 | finance.yahoo.comMicrobot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical StudyOctober 24, 2023 | finance.yahoo.comMicrobot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024October 19, 2023 | finance.yahoo.comMicrobot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against CompanyOctober 18, 2023 | markets.businessinsider.comPromising Preclinical Outcomes Propel Buy Rating for Microbot Medical: A Look into LIBERTY® Robotic Surgical SystemOctober 17, 2023 | finance.yahoo.comMicrobot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical SystemSeptember 27, 2023 | finance.yahoo.comMicrobot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical TrialSeptember 8, 2023 | finance.yahoo.comMicrobot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023August 17, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: AIM ImmunoTech (AIM), Microbot Medical (MBOT)August 16, 2023 | finance.yahoo.comIs Microbot Medical (NASDAQ:MBOT) In A Good Position To Deliver On Growth Plans?August 15, 2023 | finance.yahoo.comMicrobot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here MBOT Media Mentions By Week MBOT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBOT News Sentiment▼0.640.55▲Average Medical News Sentiment MBOT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBOT Articles This Week▼41▲MBOT Articles Average Week Get Microbot Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NEXGEL News STRATA Skin Sciences News PetVivo News GlucoTrack News Biotricity News T2 Biosystems News Plus Therapeutics News NeuroMetrix News Meihua International Medical Technologies News ProSomnus News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MBOT) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
